Gabaxuro NT 100, with its potent blend of Gabapentin (100mg) and Nortriptyline (10mg), is an advanced medication for the effective management of chronic neuropathic pain. The formulation's power lies in its dual mechanism of action: Gabapentin works by calming the hyperactive nerves that transmit pain signals, while Nortriptyline, a tricyclic antidepressant, enhances the body's natural pain-modulating chemicals and helps improve mood and sleep, which are often compromised in chronic pain conditions. This synergistic effect provides comprehensive and long-lasting relief from conditions such as diabetic neuropathy, post-herpetic neuralgia, and fibromyalgia.
The neurology and pain management segments of the Indian pharmaceutical market are experiencing sustained growth, driven by the increasing prevalence of diabetes, an aging population, and heightened awareness of neuropathic conditions. This makes a product like Gabaxuro NT 100 an ideal choice for a PCD pharma franchise. The market's stability and consistent demand ensure a steady flow of business. We offer a monopoly-based business model in your designated territory, protecting you from internal competition and allowing you to build a dominant position in the B2B supply chain for neurologists, hospitals, and pain management clinics.
We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, building trust with healthcare professionals. We provide a complete promotional and marketing kit, including product literature and visual aids, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of a top-quality neurological medication.